01717 AUSNUTRIA
- 1.930
- 0.0000.00%
AUSNUTRIA News
Ausnutria Dairy Corp Plans Key Board Meeting
Ausnutria (01717.HK) plans to hold a board of directors meeting on August 27 to approve the mid-year performance.
On August 9th, GeLongHui reported that the board of directors of Ausnutria (01717.HK) will hold a meeting on Tuesday, August 27, 2024, to (including) (i) consider and approve the mid-term performance announcement of the company and its subsidiaries for the six months ended June 30, 2024; and (ii) consider recommending the distribution of mid-term dividends (if any).
Kabrita, the #1 Goat Milk Formula Brand Globally, Expands Into Canada With the Launch of Its Toddler Nutrition
Ausnutria Dairy Announces Director Resignation
Ausnutria Dairy Unveils Board and Committee Members
Ausnutria (01717.HK): Song Kungang resigned as independent non-executive director.
Ausnutria (01717.HK) announced on July 30th that Mr. Song Kungang has resigned from the position of independent non-executive director with effective from July 30, 2024 in order to focus on other matters.
Are Ausnutria Dairy Corporation Ltd (HKG:1717) Investors Paying Above The Intrinsic Value?
Ausnutria subsidiary intends to purchase the remaining 50% equity of Amalthea Group.
Ausnutria (01717) announced that on July 4th, 2024, the company's indirect wholly-owned subsidiary (buyer) and Dairy Goat Holding B.V. (the lawful successor of the seller) entered into an implementation agreement pursuant to which the buyer will exercise the put options and purchase the remaining Amalthea Group shares held by DGH at the put option purchase price. The remaining shares, or 50.0% of the issued share capital of Amalthea Group held by DGH. The put option purchase price is expected to be approximately EUR 22.1 million. After the implementation agreement is completed, A.
Kabrita Becomes the First and Only Goat Milk-Based Infant Formula to Achieve Clean Label Project's Three Strict Certifications
AUSNUTRIA: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 30 MAY 2024
AUSNUTRIA: NOTICE OF ANNUAL GENERAL MEETING
AUSNUTRIA: ANNUAL REPORT 2023
Yili Innovation Center Europe Kicks Off All-round Upgrades
Huaxi Securities: Maintaining the Australian Excellent (01717) “Increase in holdings” rating, the profit side of collaborative development with Yili is expected to improve
Huaxi Securities expects the adjusted net profit of Ausu (01717) to increase 30% year over year.
Earnings Miss: Ausnutria Dairy Corporation Ltd Missed EPS By 42% And Analysts Are Revising Their Forecasts
Everbright Securities: Maintaining the Australian Excellent (01717) “Increase in Holdings” Rating Plan to Achieve Steady Growth in the Beef and Goat Milk Powder Business
Everbright Securities lowered the 2024-25 net profit forecast for Australian Excellent (01717) to $272/351 million, respectively.
Net profit due to equity holders of Ausu (01717.HK) in 2023 of RMB 174 million fell 19.4% year-on-year
On March 27, GLONGHUI (01717.HK) announced that in 2023, the company's revenue was RMB 7,382.0 million, a year-on-year decrease of RMB 413.5 million or 5.3%. Gross profit was RMB 2,852.6 million, a year-on-year decrease of RMB 540.2 million, or 15.9%. Net profit attributable to company equity holders was RMB 174.4 million, a year-on-year decrease of RMB 42.1 million or 19.4%. Despite this, the company's own brand of goat milk powder has the highest share in the Chinese market. Judging from international business, Jiabeite goat milk powder
Ausu (01717) will pay a final dividend of HK$0.05 per share on June 25
Aoyou (01717) announced that the company will pay a final dividend of 0.05 per share on June 25, 2024...
AUSNUTRIA: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Aoyou (01717.HK) will hold a board meeting on March 27 to approve the annual results
On March 15, GLONGHUI (01717.HK) announced that the company's board of directors meeting will be held on March 27, 2024 to review and approve the Group's annual results and announcements for the year ended December 31, 2023, and consider the proposal to pay a final dividend (if any).
Analysis
Price Target
No Data
